Video

Women in Oncology: How Has the Culture of Oncology Practice Changed Regarding Gender Disparities?

Laura Farrington, DO, Elesyia Outlaw-Evans, MD, and Ruchi Garg, MD, share insight on how the corporate culture has changed in oncology practices with regard to gender inequality.

Laura Farrington, DO, a medical oncologist at CTCA Chicago; Elesyia Outlaw-Evans, MD, a radiation oncologist at CTCA Pheonix; and Ruchi Garg, MD, CTCA Program Director of Gynecologic Oncology and gynecologic oncologist at CTCA Atlanta, share insight on how the corporate culture has changed in oncology practices with regard to gender inequality.

The 3 experts sat down to be candid and discuss their variety of experiences throughout their career, what the culture of their work environments were like, the obstacles they came into contact with and how they overcame them, and how society has changed from their early days until now.

Notably, in this exclusive interview, they highlight advice to up-and-upcoming female oncologists on navigating these waters today.

In this episode, the 3 experts discuss in detail how they believe the corporate culture of oncology practices have evolved over the years as it relates to gender-related disparities, and what work still needs to be done in this area.


Related Videos
Jonathan Spicer, MD, PhD, FRCS
Daniel DeAngelo, MD, PhD
Marc J. Braunstein, MD, PhD, associate professor, Department of Medicine, co-director, Hematology-Oncology System, New York University (NYU) Grossman Long Island School of Medicine
Douglas W. Sborov, MD, MS, associate professor, Department of Internal Medicine—Division of Hematology and Hematologic Malignancies; director, Hematology Disease Center and Plasma Cell Dyscrasias Program, the University of Utah Huntsman Cancer Institute
Bradley C. Carthon, MD, PhD
David C. Fisher, MD
Alan Tan, MD
Binod Dhakal, MD
Sheldon M. Feldman, MD
Yair Lotan, MD, UT Southwestern Medical Center